An FDA advisory committee voted to recommend Merck's antiviral covid pill molnupiravir for emergency use authorization. The FDA could sign off in days.
A panel of health experts appointed by the US government will meet Tuesday to decide whether to endorse Merck's pill to treat Covid-19, potentially paving the way for the medicine to be available wit…
If authorized, Merck’s pill would be the first that U.S. patients could take at home to ease symptoms and speed recovery, a major step toward reducing hospital case loads and deaths
WASHINGTON (AP) — A panel of U.S. health advisers on Tuesday narrowly backed a closely watched COVID-19 pill from Merck, setting the stage for a likely authorization of the first
WASHINGTON (AP) — Government health advisers on Tuesday weighed the benefits and risks of a closely watched drug from Merck that could soon become the first U.S.-authorized pill for patients
Government health advisers on Tuesday weighed the benefits and risks of a closely watched drug from Merck that could soon become the first U.S.-authorized pill for patients to take at home to treat COVID-19.
The FDA asked its outside advisers whether it should authorize the COVID-19 pill, weighing new information that it is less effective than first reported and may cause birth defects.
The meeting marks the first time regulators have publicly reviewed a new drug for COVID-19, reflecting the intense interest and scrutiny of a pill that could be soon used by millions of Americans.
WASHINGTON (AP) — A panel of U.S. health advisers on Tuesday narrowly backed a closely watched COVID-19 pill from Merck, setting the stage for a likely authorization of the first
The FDA’s Antimicrobial Drugs Advisory Committee voted 13 to 10 to recommend emergency authorization of molnupiravir, an oral antiviral drug to fight Covid.
If authorized, the pill would be the first that doctors could prescribe for patients to take on their own to ease symptoms and speed recovery, a major step toward reducing hospital caseloads and deaths.
By Maggie Fox and Jen Christensen, CNN Advisers to the US Food and Drug Administration voted 13-10 Tuesday to recommend emergency use authorization of a pill made by Merck and Ridgeback Biotherapeutics to help treat Covid-19.
Merck’s pill could provide a much-needed therapy as colder weather pushes case counts higher and U.S. officials brace for the arrival of the new omicron variant.
